168 related articles for article (PubMed ID: 10051546)
1. Role of a conserved lysine residue in the peripheral cannabinoid receptor (CB2): evidence for subtype specificity.
Tao Q; McAllister SD; Andreassi J; Nowell KW; Cabral GA; Hurst DP; Bachtel K; Ekman MC; Reggio PH; Abood ME
Mol Pharmacol; 1999 Mar; 55(3):605-13. PubMed ID: 10051546
[TBL] [Abstract][Full Text] [Related]
2. Mutational analysis and molecular modelling of the antagonist SR 144528 binding site on the human cannabinoid CB(2) receptor.
Gouldson P; Calandra B; Legoux P; Kernéis A; Rinaldi-Carmona M; Barth F; Le Fur G; Ferrara P; Shire D
Eur J Pharmacol; 2000 Jul; 401(1):17-25. PubMed ID: 10915832
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands.
Showalter VM; Compton DR; Martin BR; Abood ME
J Pharmacol Exp Ther; 1996 Sep; 278(3):989-99. PubMed ID: 8819477
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the cannabinoid CB2 receptor-selective antagonist, SR144528: further evidence for cannabinoid CB2 receptor absence in the rat central nervous system.
Griffin G; Wray EJ; Tao Q; McAllister SD; Rorrer WK; Aung MM; Martin BR; Abood ME
Eur J Pharmacol; 1999 Jul; 377(1):117-25. PubMed ID: 10448934
[TBL] [Abstract][Full Text] [Related]
5. The third transmembrane helix of the cannabinoid receptor plays a role in the selectivity of aminoalkylindoles for CB2, peripheral cannabinoid receptor.
Chin CN; Murphy JW; Huffman JW; Kendall DA
J Pharmacol Exp Ther; 1999 Nov; 291(2):837-44. PubMed ID: 10525107
[TBL] [Abstract][Full Text] [Related]
6. Novel insights into CB1 cannabinoid receptor signaling: a key interaction identified between the extracellular-3 loop and transmembrane helix 2.
Marcu J; Shore DM; Kapur A; Trznadel M; Makriyannis A; Reggio PH; Abood ME
J Pharmacol Exp Ther; 2013 May; 345(2):189-97. PubMed ID: 23426954
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the role of nicotinic acetylcholine receptor subtypes and cannabinoid system in the discriminative stimulus effects of nicotine in rats.
Zaniewska M; McCreary AC; Przegaliński E; Filip M
Eur J Pharmacol; 2006 Jul; 540(1-3):96-106. PubMed ID: 16730696
[TBL] [Abstract][Full Text] [Related]
8. The bioactive conformation of aminoalkylindoles at the cannabinoid CB1 and CB2 receptors: insights gained from (E)- and (Z)-naphthylidene indenes.
Reggio PH; Basu-Dutt S; Barnett-Norris J; Castro MT; Hurst DP; Seltzman HH; Roche MJ; Gilliam AF; Thomas BF; Stevenson LA; Pertwee RG; Abood ME
J Med Chem; 1998 Dec; 41(26):5177-87. PubMed ID: 9857088
[TBL] [Abstract][Full Text] [Related]
9. Mapping the structural requirements in the CB1 cannabinoid receptor transmembrane helix II for signal transduction.
Kapur A; Samaniego P; Thakur GA; Makriyannis A; Abood ME
J Pharmacol Exp Ther; 2008 Apr; 325(1):341-8. PubMed ID: 18174385
[TBL] [Abstract][Full Text] [Related]
10. Ligand binding and modulation of cyclic AMP levels depend on the chemical nature of residue 192 of the human cannabinoid receptor 1.
Chin CN; Lucas-Lenard J; Abadji V; Kendall DA
J Neurochem; 1998 Jan; 70(1):366-73. PubMed ID: 9422383
[TBL] [Abstract][Full Text] [Related]
11. Mutation studies of Ser7.39 and Ser2.60 in the human CB1 cannabinoid receptor: evidence for a serine-induced bend in CB1 transmembrane helix 7.
Kapur A; Hurst DP; Fleischer D; Whitnell R; Thakur GA; Makriyannis A; Reggio PH; Abood ME
Mol Pharmacol; 2007 Jun; 71(6):1512-24. PubMed ID: 17384224
[TBL] [Abstract][Full Text] [Related]
12. Sphingosine and its analog, the immunosuppressant 2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol, interact with the CB1 cannabinoid receptor.
Paugh SW; Cassidy MP; He H; Milstien S; Sim-Selley LJ; Spiegel S; Selley DE
Mol Pharmacol; 2006 Jul; 70(1):41-50. PubMed ID: 16571654
[TBL] [Abstract][Full Text] [Related]
13. Mutation of a highly conserved aspartate residue in the second transmembrane domain of the cannabinoid receptors, CB1 and CB2, disrupts G-protein coupling.
Tao Q; Abood ME
J Pharmacol Exp Ther; 1998 May; 285(2):651-8. PubMed ID: 9580609
[TBL] [Abstract][Full Text] [Related]
14. Activation of brain-type cannabinoid receptors interferes with preimplantation mouse embryo development.
Yang ZM; Paria BC; Dey SK
Biol Reprod; 1996 Oct; 55(4):756-61. PubMed ID: 8879486
[TBL] [Abstract][Full Text] [Related]
15. Effects of cannabinoid receptor agonist and antagonist ligands on production of inflammatory cytokines and anti-inflammatory interleukin-10 in endotoxemic mice.
Smith SR; Terminelli C; Denhardt G
J Pharmacol Exp Ther; 2000 Apr; 293(1):136-50. PubMed ID: 10734163
[TBL] [Abstract][Full Text] [Related]
16. The anti-inflammatory activities of cannabinoid receptor ligands in mouse peritonitis models.
Smith SR; Denhardt G; Terminelli C
Eur J Pharmacol; 2001 Nov; 432(1):107-19. PubMed ID: 11734194
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid CB1 receptor-mediated inhibition of the neurogenic vasopressor response in the pithed rat.
Malinowska B; Godlewski G; Bucher B; Schlicker E
Naunyn Schmiedebergs Arch Pharmacol; 1997 Aug; 356(2):197-202. PubMed ID: 9272725
[TBL] [Abstract][Full Text] [Related]
18. Species comparison and pharmacological characterization of rat and human CB2 cannabinoid receptors.
Mukherjee S; Adams M; Whiteaker K; Daza A; Kage K; Cassar S; Meyer M; Yao BB
Eur J Pharmacol; 2004 Nov; 505(1-3):1-9. PubMed ID: 15556131
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of interleukin-8 release in the human colonic epithelial cell line HT-29 by cannabinoids.
Ihenetu K; Molleman A; Parsons ME; Whelan CJ
Eur J Pharmacol; 2003 Jan; 458(1-2):207-15. PubMed ID: 12498928
[TBL] [Abstract][Full Text] [Related]
20. Modulation of gastric emptying and gastrointestinal transit in rats through intestinal cannabinoid CB(1) receptors.
Landi M; Croci T; Rinaldi-Carmona M; Maffrand JP; Le Fur G; Manara L
Eur J Pharmacol; 2002 Aug; 450(1):77-83. PubMed ID: 12176112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
